Century Therapeutics, Inc. (IPSC) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 7 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for IPSC is $3.00, representing a +26.6% upside from the current price of $2.37. Price targets range from a low of $2.00 to a high of $4.00.
